These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Longer term assessment of photodynamic therapy for intimal hyperplasia: a pilot study. Cheung J; Todd M; Turnbull R; Allison B; Mornin L; Carvalho AM; Spurr G; Hsiang Y J Photochem Photobiol B; 2004 Feb; 73(3):141-7. PubMed ID: 14975402 [TBL] [Abstract][Full Text] [Related]
27. Photodynamic therapy of human malignant melanoma xenografts in athymic nude mice. Nelson JS; McCullough JL; Berns MW J Natl Cancer Inst; 1988 Mar; 80(1):56-60. PubMed ID: 2963136 [TBL] [Abstract][Full Text] [Related]
28. Adjuvant intraoperative photodynamic therapy in experimental colorectal cancer using a new photosensitizer. Abulafi AM; DeJode ML; Allardice JT; Ansell JK; Williams NS Br J Surg; 1997 Mar; 84(3):368-71. PubMed ID: 9117310 [TBL] [Abstract][Full Text] [Related]
29. Photodynamic therapy in the management of bladder cancer. Nseyo UO J Clin Laser Med Surg; 1996 Oct; 14(5):271-80. PubMed ID: 9612193 [TBL] [Abstract][Full Text] [Related]
30. Preclinical Study of Antineoplastic Sinoporphyrin Sodium-PDT via In Vitro and In Vivo Models. Shi R; Li C; Jiang Z; Li W; Wang A; Wei J Molecules; 2017 Jan; 22(1):. PubMed ID: 28085075 [TBL] [Abstract][Full Text] [Related]
31. Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts. Peng Q; Warloe T; Moan J; Godal A; Apricena F; Giercksky KE; Nesland JM Cancer Res; 2001 Aug; 61(15):5824-32. PubMed ID: 11479222 [TBL] [Abstract][Full Text] [Related]
32. Tumor blood-flow changes following protoporphyrin IX-based photodynamic therapy in mice and humans. Herman MA; Fromm D; Kessel D J Photochem Photobiol B; 1999; 52(1-3):99-104. PubMed ID: 10643075 [TBL] [Abstract][Full Text] [Related]
33. Photodynamic therapy of head and neck tumors and non-tumor like disorders. Gerber-Leszczyszyn H; Ziółkowski P; Marszalik P Otolaryngol Pol; 2004; 58(2):339-43. PubMed ID: 15307481 [TBL] [Abstract][Full Text] [Related]
34. Photodynamic cell killing effects and acute skin photosensitivity of aluminum-chloro-tetrasulfonated phthalocyanine and hematoporphyrin derivative. Komatsu K Jpn J Cancer Res; 1991 May; 82(5):599-606. PubMed ID: 1905706 [TBL] [Abstract][Full Text] [Related]
37. A comparative analysis of silicon phthalocyanine photosensitizers for in vivo photodynamic therapy of RIF-1 tumors in C3H mice. Anderson CY; Freye K; Tubesing KA; Li YS; Kenney ME; Mukhtar H; Elmets CA Photochem Photobiol; 1998 Mar; 67(3):332-6. PubMed ID: 9523532 [TBL] [Abstract][Full Text] [Related]
38. Advantages of laserphyrin compared with photofrin in photodynamic therapy for bile duct carcinoma. Nonaka T; Nanashima A; Nonaka M; Uehara M; Isomoto H; Nonaka Y; Nagayasu T J Hepatobiliary Pancreat Sci; 2011 Jul; 18(4):592-600. PubMed ID: 21360081 [TBL] [Abstract][Full Text] [Related]
39. Schedule-dependent interaction between Doxorubicin and mTHPC-mediated photodynamic therapy in murine hepatoma in vitro and in vivo. Kirveliene V; Grazeliene G; Dabkeviciene D; Micke I; Kirvelis D; Juodka B; Didziapetriene J Cancer Chemother Pharmacol; 2006 Jan; 57(1):65-72. PubMed ID: 16001168 [TBL] [Abstract][Full Text] [Related]
40. Induction of apoptotic cell death by photodynamic therapy in human keratinocytes. Ketabchi A; MacRobert A; Speight PM; Bennett JH Arch Oral Biol; 1998 Feb; 43(2):143-9. PubMed ID: 9602293 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]